Aptiv PLC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Kevin P Clark, Chair and CEO and a Director of Aptiv PLC, reported a transaction in 51,190 shares of common stock on August 12, 2026.
NYSE
Sean O Mahoney, a Director of Aptiv PLC, purchased 11,000 shares of common stock on August 11, 2026.
NYSE
Paul M Meister, a Director of Aptiv PLC, purchased 105,631 shares of common stock on August 5, 2026 for $47.33 per share.
NYSE
Allan J Brazier, SVP & Chief Accounting Officer of Aptiv PLC, reported a transaction in 4,062 shares of common stock on July 14, 2026.
NYSE
Aptiv PLC executive Obed D. Louissaint sold 3,000 ordinary shares for $69.60 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Katherine H. Ramundo, EVP and CLO of Aptiv PLC, sold 2,000 shares of common stock under a pre-established 10b5-1 trading plan.
NYSE
Aptiv PLC reports that Director Hakan Agnevall acquired 6,100 ordinary shares on May 8, 2026, for an average price of $57.73 per share.
NYSE
Director Ana G. Pinczuk reported the acquisition of restricted stock units and the withholding of shares for tax obligations.
NYSE
Aptiv PLC reports on stock transactions by Katherine H. Ramundo, EVP, CLO, CCO & Secretary, involving ordinary shares and performance awards.
NYSE
Joseph R. Massaro, Vice Chair & President, EC at Aptiv PLC, reported a transaction involving ordinary shares on April 22, 2026.
NYSE
Aptiv PLC executive Obed D. Louissaint reported transactions involving ordinary shares, including acquisitions and performance-based awards.
NYSE
Aptiv PLC executive Varun Laroyia reported transactions involving ordinary shares, including acquisitions and adjustments due to a corporate spin-off.
NYSE
Aptiv PLC reports that CEO Kevin P. Clark acquired a significant number of ordinary shares through a transaction on April 22, 2026, with vesting conditions attached.
NYSE
Aptiv PLC executive Allan J. Brazier reported transactions involving ordinary shares, including acquisitions under incentive plans.
NYSE
Aptiv PLC reported the disposition of 70.9 million Versigent PLC ordinary shares through a spin-off distribution to its shareholders.
NYSE
Aptiv PLC's Vice Chair and President, Joseph R. Massaro, reported an acquisition of shares due to performance achievement and a disposition to cover tax liabilities.
NYSE
Aptiv EVP Javed A. Khan disposed of 5,875 ordinary shares to cover tax liabilities related to restricted stock unit vesting.
NYSE
Aptiv's EVP & Chief People Officer, Obed D. Louissaint, reported the acquisition of shares due to performance and the disposition of shares for tax liabilities.
NYSE
Aptiv's EVP, CLO, CCO & Secretary, Katherine H. Ramundo, acquired 5,509 ordinary shares for performance and disposed of 13,160 shares for tax liabilities.
NYSE
Aptiv's SVP & Chief Accounting Officer, Allan J. Brazier, reported the acquisition of shares due to performance and the disposition of shares for tax liabilities.
NYSE
Aptiv PLC's EVP & CFO, Varun Laroyia, disposed of 8,626 ordinary shares to cover tax liabilities from restricted stock unit vesting.
NYSE
Aptiv EVP Joseph T. Liotine disposed of 5,296 ordinary shares to cover tax liabilities related to restricted stock unit vesting.
NYSE
Aptiv PLC's Chair and CEO, Kevin P. Clark, reported the acquisition of 31,137 ordinary shares due to performance and the disposition of 164,103 shares for tax and other reasons.
NYSE
Aptiv's EVP, CLO, CCO & Secretary, Katherine H. Ramundo, sold 5,000 ordinary shares for $85 each, reducing her beneficial ownership to 116,959 shares.
NYSE
Aptiv's EVP & CFO, Varun Laroyia, reported a planned sale of 5,000 ordinary shares for $80.05 each on December 12, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
Aptiv PLC's Chair and CEO, Kevin P. Clark, reported a gift of 25,320 ordinary shares, executed under a Rule 10b5-1 plan.
NYSE
Aptiv PLC Director Hakan Agnevall plans to acquire 3,700 ordinary shares for approximately $297,000 on December 12, 2025.
NYSE
Aptiv PLC Director Hakan Agnevall was granted 955 restricted stock units, vesting in 2026, as part of the company's Long Term Incentive Plan.
NYSE
Aptiv's EVP & CFO, Varun Laroyia, sold 14,500 ordinary shares for $77.88 each, pursuant to a pre-arranged 10b5-1 trading plan.
NYSE
Aptiv PLC Director Sean O. Mahoney sold 7,881 ordinary shares for $76.6 each, executed under a pre-arranged 10b5-1 trading plan.